| Scorpion venom peptides with no disulfide bridges: a review A Almaaytah, Q Albalas Peptides 51, 35-45, 2014 | 202 | 2014 |
| Development of novel ultrashort antimicrobial peptide nanoparticles with potent antimicrobial and antibiofilm activities against multidrug-resistant bacteria A Almaaytah, GK Mohammed, A Abualhaijaa, Q Al-Balas Drug design, development and therapy, 3159-3170, 2017 | 93 | 2017 |
| Identification of 2-Aminothiazole-4-Carboxylate Derivatives Active against Mycobacterium tuberculosis H37Rv and the β-Ketoacyl-ACP Synthase mtFabH Q Al-Balas, NG Anthony, B Al-Jaidi, A Alnimr, G Abbott, AK Brown, ... PLoS One 4 (5), e5617, 2009 | 78 | 2009 |
| Mauriporin, a novel cationic α-helical peptide with selective cytotoxic activity against prostate cancer cell lines from the venom of the scorpion Androctonus mauritanicus A Almaaytah, S Tarazi, N Mhaidat, Q Al-Balas, TL Mukattash International journal of peptide research and therapeutics 19, 281-293, 2013 | 54 | 2013 |
| Antimicrobial and antibiofilm activity of UP-5, an ultrashort antimicrobial peptide designed using only arginine and biphenylalanine A Almaaytah, MT Qaoud, G Khalil Mohammed, A Abualhaijaa, D Knappe, ... Pharmaceuticals 11 (1), 3, 2018 | 53 | 2018 |
| Cytotoxic Homoisoflavones from the Bulbs of Bellevalia eigii F Alali, T El-Elimat, H Albataineh, Q Al-Balas, M Al-Gharaibeh, ... Journal of natural products 78 (7), 1708-1715, 2015 | 48 | 2015 |
| Enhanced antimicrobial activity of AamAP1-Lysine, a novel synthetic peptide analog derived from the scorpion venom peptide AamAP1 A Almaaytah, S Tarazi, A Abu-Alhaijaa, Y Altall, N Alshar’i, K Bodoor, ... Pharmaceuticals 7 (5), 502-516, 2014 | 48 | 2014 |
| Hybridization and antibiotic synergism as a tool for reducing the cytotoxicity of antimicrobial peptides A Almaaytah, MT Qaoud, A Abualhaijaa, Q Al-Balas, KH Alzoubi Infection and drug resistance, 835-847, 2018 | 43 | 2018 |
| Generation of the first structure-based pharmacophore model containing a selective “zinc binding group” feature to identify potential glyoxalase-1 inhibitors Q Al-Balas, M Hassan, B Al-Oudat, H Alzoubi, N Mhaidat, A Almaaytah Molecules 17 (12), 13740-13758, 2012 | 43 | 2012 |
| Antimicrobial and antibiofilm activity of mauriporin, a multifunctional scorpion venom peptide A Almaaytah, S Tarazi, F Alsheyab, Q Al-Balas, T Mukattash International journal of peptide research and therapeutics 20, 397-408, 2014 | 34 | 2014 |
| A3, a scorpion venom derived peptide analogue with potent antimicrobial and potential antibiofilm activity against clinical isolates of multi-drug resistant gram positive bacteria A Almaaytah, A Farajallah, A Abualhaijaa, Q Al-Balas Molecules 23 (7), 1603, 2018 | 31 | 2018 |
| Novel glyoxalase-I inhibitors possessing a “zinc-binding feature” as potential anticancer agents QA Al-Balas, MA Hassan, NA Al-Shar’i, NM Mhaidat, AM Almaaytah, ... Drug design, development and therapy, 2623-2629, 2016 | 29 | 2016 |
| GRP78 regulates sensitivity of human colorectal cancer cells to DNA targeting agents NM Mhaidat, KH Alzoubi, OF Khabour, MN Banihani, QA Al-Balas, ... Cytotechnology 68, 459-467, 2016 | 27 | 2016 |
| Recent advances in glyoxalase-I inhibition QA Al-Balas, MA Hassan, NA Al-Shar'i, GA Al Jabal, AM Almaaytah Mini Reviews in Medicinal Chemistry 19 (4), 281-291, 2019 | 25 | 2019 |
| Combination of pharmacophore modeling and 3D-QSAR analysis of potential glyoxalase-I inhibitors as anticancer agents MA Al-Sha'er, QA Al-Balas, MA Hassan, GA Al Jabal, AM Almaaytah Computational Biology and Chemistry 80, 102-110, 2019 | 24 | 2019 |
| Molecular dynamics simulations of adenosine receptors: Advances, applications and trends NA Al-Shar'i, QA Al-Balas Current pharmaceutical design 25 (7), 783-816, 2019 | 24 | 2019 |
| Virtual lead identification of farnesyltransferase inhibitors based on ligand and structure-based pharmacophore techniques QA Al-Balas, HA Amawi, MA Hassan, AM Qandil, AM Almaaytah, ... Pharmaceuticals 6 (6), 700-715, 2013 | 24 | 2013 |
| Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators MMA Buthina Abdallah Al-Oudat, Mohammad Ali Alqudah, Suaad Abdallah Audat ... Drug Design, Development and Therapy 13, 423–433, 2019 | 23 | 2019 |
| Ellagic Acid: A Potent Glyoxalase-I Inhibitor with a Unique Scaffold AMA Nizar A. Al-Shar’i, Qosay A. Al-Balas, Mohammad A. Hassan, Tamam El ... Acta Pharmaceutica 71, 115–130, 2021 | 21 | 2021 |
| Withania somnifera root powder protects againist post-traumatic stress disorder-induced memory impairment KH Alzoubi, AS Al Hilo, QA Al-Balas, K El-Salem, T El-Elimat, FQ Alali Molecular Biology Reports 46, 4709-4715, 2019 | 21 | 2019 |
Ammar AlmaaytahDean and Professor of Pharmaceutical Biotechnology, Jordan University of Science & Technology在 just.edu.jo 的电子邮件经过验证
